Bionexus Gene Lab Corp
BGLC
Revenue
1.97M
▼-407.29k▼-17.10%
3 Months ChangeAssets
11.14M
▼-21.76k▼-0.1949%
3 Months ChangeLiabilities
1.59M
▼-223.32k▼-12.29%
3 Months ChangeFree Cash Flow
-116.62k
▼-46.59k▼-66.53%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-15
Form 8-K
ID: 0001477932-24-006440
2024-10-10
Form 8-K
ID: 0001477932-24-006352
2024-09-25
Form 8-K
ID: 0001477932-24-005924
2024-09-18
Form 8-K
ID: 0001477932-24-005817
2024-09-12
Form 8-K
ID: 0001477932-24-005680
2024-09-05
Form 8-K
ID: 0001477932-24-005537
2024-08-28
Form 8-K
ID: 0001477932-24-005339
2024-08-26
Form 8-K
ID: 0001477932-24-005269
2024-08-14
Form 10-Q
ID: 0001477932-24-004792
2024-05-15
Form 10-Q
ID: 0001477932-24-002941